Arsenic Trioxide in Combination with All-Trans Retinoic Acid for the Treatment of Newly Diagnosed Patients with High-Risk APL By Ogkologos - September 3, 2025 539 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the APOLLO study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Why the voices of people affected by cancer are critical to... November 23, 2020 Cancer in My Community: The Role of Cancer Screening in Guatemala November 5, 2020 Merging the Histologic and Molecular Data Into an Integrated Score Significantly... October 11, 2021 Survivor Sees Mom Fighting Breast Cancer At Brunch And Pays For... December 2, 2019 Load more HOT NEWS Mom Battling Cancer Lets 4-Yr-Old Give Her “Best Haircut Ever.” Higher Pregnancy Rates and No Impact on Prognosis with Embryo/Oocyte Cryopreservation... October is National Dental Hygiene Month Rucaparib Extends PFS in the Maintenance Treatment of Recurrent EOC Without...
